MedPath

The effect of FSH administration with HCG at the time of trigger on IVF cycles outcomes

Phase 2
Conditions
Female infertility.
Female infertility,unspecified
N97.9
Registration Number
IRCT2017082724512N5
Lead Sponsor
Deputy of Research and Technology, Shahid Sadoughi University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
152
Inclusion Criteria

Infertile women who candidate for IVF cycles underwent GnRH antagonist protocol
Fresh embryo transfer cycles

Exclusion Criteria

Women with history of endocrine disorders
serum estradiol>2500pg/ml in day of trigger
Intrauterine abnormality (uterine polyp; uterine myoma)
Severe male factor
Cycle cancellation or changing to intrauterine insemination
A cycle containing preimplantation genetic diagnosis (PGD)
Women who did not undergo embryo transfer due to the freeze-all policy
Donor or surrogate cycle

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 14 days after transfer. Method of measurement: BHCG test.;Clinical pregnancy. Timepoint: 2 weeks after positive BHCG. Method of measurement: Transvaginal sonography.
Secondary Outcome Measures
NameTimeMethod
Fertilization proportion. Timepoint: Post oocyte retrival. Method of measurement: The number of fertilized oocytes divided by the total number of oocytes.;Oocyte recovery rate. Timepoint: After oocyte retrieval. Method of measurement: The number of retrieved oocytes divided by the number of follicles >10 mm in size counted on the day of trigger.;Oocyte maturity rate. Timepoint: After oocyte retrieval. Method of measurement: the number of metaphase II (MII) oocytes divided by the number of oocytes retrieved.;Fertilization rate. Timepoint: After formation of 2PNs. Method of measurement: the number of 2PNs divided by the total number of MII oocytes.;Implantation rate. Timepoint: After detection of gestational sac in ultrasonography. Method of measurement: the number of intrauterine gestational sacs observed by transvaginal ultrasonography divided by the total number of transferred embryos.
© Copyright 2025. All Rights Reserved by MedPath